Table 2. Estimated Annual Incidence Rates* of Community-acquired Pneumonia Hospitalization by Year, Site, Age Group, and Pathogen Detected.
Variable | Annual no. pneumonia hospitalizations/10,000 children | 95% confidence interval |
---|---|---|
| ||
Overall incidence rate† | 15.7 | 14.9–16.5 |
2010-2011 (year 1) | 16.8 | 15.6-18.0 |
2011-2012 (year 2) | 14.6 | 13.5-15.7 |
| ||
Study Site | ||
Memphis | 19.6 | 18.0–21.3 |
Nashville | 12.3 | 11.2–13.4 |
Salt Lake City | 15.2 | 13.8–16.5 |
| ||
Age group | ||
<2 years | 62.2 | 57.6–67.1 |
2-4 years | 23.8 | 21.4–26.3 |
5-9 years | 10.1 | 8.9–11.3 |
10-17 years | 4.2 | 3.6–4.8 |
| ||
Pathogen-specific incidence‡ | ||
Respiratory Syncytial Virus | 4.6 | 4.3–5.1 |
Human Rhinovirus | 4.1 | 3.7–4.4 |
Human Metapneumovirus | 1.9 | 1.6–2.1 |
Adenovirus | 1.6 | 1.4–1.8 |
Mycoplasma pneumoniae | 1.4 | 1.2–1.6 |
Influenza A/B virus | 1.1 | 0.9–1.3 |
Parainfluenza viruses 1-3 | 0.9 | 0.8–1.1 |
Coronaviruses | 0.8 | 0.7–1.0 |
Streptococcus pneumoniae | 0.5 | 0.4–0.6 |
Based on 2,212,327 person-years of observation
Annual incidence rates were calculated from July 1, 2010 to June 30, 2011 (year 1) and July 1, 2011 to June 30, 2012 (year 2) and represent the 2012 children with radiographic pneumonia enrolled during that time
Pathogen-specific incidence is calculated for the 1899 children with radiographic pneumonia during the incidence period with at least one specimen available for both bacterial and viral testing. Age-specific pathogen-specific incidence is in Supplementary Table S6.